| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4220299 | Academic Radiology | 2008 | 8 Pages |
Abstract
DCE-MRI and IHC can be used in patients with MM to visualize tumor microvascularity and to characterize tumor heterogeneity. DCE-MRI and IHC results positively correlated, though moderately, but these two methods present as essential tumor biomarkers. This multimodal characterization may be useful in selecting possible tumor subtypes that would benefit from antiangiogenic therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Frederik L. MD, MBA, Peter L. MD, Amit MBBS, Christian M. MD, Henrik MD, Klaus MD, Helge MD, Christian MD, Stefan MD, M.A. MD, MSc, Marco MD, Hans-Ulrich MD, Michael V. MD, PhD,